{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:03:55Z","timestamp":1791684235486,"version":"4.3.4"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T00:00:00Z","timestamp":1304985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1038\/nrendo.2011.72","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T09:42:06Z","timestamp":1305020526000},"page":"456-465","source":"Crossref","is-referenced-by-count":291,"title":["Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment"],"prefix":"10.1038","volume":"7","author":[{"given":"Briohny W.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon A.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,10]]},"reference":[{"key":"BFnrendo201172_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221\u20131231 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201172_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","volume":"37","author":"BA Neuschwander-Tetri","year":"2003","unstructured":"Neuschwander-Tetri, B. A. & Caldwell, S. H. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37, 1202\u20131219 (2003).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cgh.2008.11.005","volume":"7","author":"N Rafiq","year":"2009","unstructured":"Rafiq, N. et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin. Gastroenterol. Hepatol. 7, 234\u2013238 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrendo201172_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.2337\/diacare.22.5.756","volume":"22","author":"R de Marco","year":"1999","unstructured":"de Marco, R. et al. Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care 22, 756\u2013761 (1999).","journal-title":"Diabetes Care"},{"key":"BFnrendo201172_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","volume":"87","author":"JE Shaw","year":"2010","unstructured":"Shaw, J. E., Sicree, R. A. & Zimmet, P. Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87, 4\u201314 (2010).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"BFnrendo201172_CR6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"J Ludwig","year":"1980","unstructured":"Ludwig, J., Viggiano, T. R., McGill, D. B. & Oh, B. J. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 55, 434\u2013438 (1980).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrendo201172_CR7","first-page":"283","volume":"8","author":"F Schaffner","year":"1986","unstructured":"Schaffner, F. & Thaler, H. Nonalcoholic fatty liver disease. Prog. Liver Dis. 8, 283\u2013298 (1986).","journal-title":"Prog. Liver Dis."},{"key":"BFnrendo201172_CR8","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","volume":"98","author":"JM Clark","year":"2003","unstructured":"Clark, J. M., Brancati, F. L. & Diehl, A. M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 98, 960\u2013967 (2003).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrendo201172_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/hep.20466","volume":"40","author":"JD Browning","year":"2004","unstructured":"Browning, J. D. et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387\u20131395 (2004).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","volume":"43","author":"JG Fan","year":"2005","unstructured":"Fan, J. G. et al. Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. J. Hepatol. 43, 508\u2013514 (2005).","journal-title":"J. Hepatol."},{"key":"BFnrendo201172_CR11","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/j.1464-5491.2005.01582.x","volume":"22","author":"S Jimba","year":"2005","unstructured":"Jimba, S. et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet. Med. 22, 1141\u20131145 (2005).","journal-title":"Diabet. Med."},{"key":"BFnrendo201172_CR12","first-page":"345","volume":"88","author":"H Nomura","year":"1997","unstructured":"Nomura, H., Hayashi, J., Kajiyama, W. & Kashiwagi, S. Prevalence of liver abnormalities in the general population of Okinawa, Japan. Fukuoka Igaku Zasshi 88, 345\u2013351 (1997).","journal-title":"Fukuoka Igaku Zasshi"},{"key":"BFnrendo201172_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.20734","volume":"42","author":"G Bedogni","year":"2005","unstructured":"Bedogni, G. et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42, 44\u201352 (2005).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR14","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1542\/peds.2006-1212","volume":"118","author":"JB Schwimmer","year":"2006","unstructured":"Schwimmer, J. B. et al. Prevalence of fatty liver in children and adolescents. Pediatrics 118, 1388\u20131393 (2006).","journal-title":"Pediatrics"},{"key":"BFnrendo201172_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1053\/jhep.2003.50161","volume":"37","author":"G Marchesini","year":"2003","unstructured":"Marchesini, G. et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917\u2013923 (2003).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/hep.1840110114","volume":"11","author":"EE Powell","year":"1990","unstructured":"Powell, E. E. et al. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 11, 74\u201380 (1990).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/0016-5085(94)90235-6","volume":"107","author":"BR Bacon","year":"1994","unstructured":"Bacon, B. R., Farahvash, M. J., Janney, C. G. & Neuschwander-Tetri, B. A. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107, 1103\u20131109 (1994).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0022-3476(95)70156-7","volume":"127","author":"AD Baldridge","year":"1995","unstructured":"Baldridge, A. D., Perez-Atayde, A. R., Graeme-Cook, F., Higgins, L. & Lavine, J. E. Idiopathic steatohepatitis in childhood: a multicenter retrospective study. J. Pediatr. 127, 700\u2013704 (1995).","journal-title":"J. Pediatr."},{"key":"BFnrendo201172_CR19","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/hep.510300604","volume":"30","author":"P Angulo","year":"1999","unstructured":"Angulo, P., Keach, J. C., Batts, K. P. & Lindor, K. D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30, 1356\u20131362 (1999).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/qjmed\/92.2.73","volume":"92","author":"H Knobler","year":"1999","unstructured":"Knobler, H. et al. Fatty liver\u2014an additional and treatable feature of the insulin resistance syndrome. QJM 92, 73\u201379 (1999).","journal-title":"QJM"},{"key":"BFnrendo201172_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00005176-200001000-00017","volume":"30","author":"M Rashid","year":"2000","unstructured":"Rashid, M. & Roberts, E. A. Nonalcoholic steatohepatitis in children. J. Pediatr. Gastroenterol. Nutr. 30, 48\u201353 (2000).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnrendo201172_CR22","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/archsurg.138.11.1240","volume":"138","author":"C Beymer","year":"2003","unstructured":"Beymer, C. et al. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery. Arch. Surg. 138, 1240\u20131244 (2003).","journal-title":"Arch. Surg."},{"key":"BFnrendo201172_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1572-0241.2006.01041.x","volume":"102","author":"PM Gholam","year":"2007","unstructured":"Gholam, P. M., Flancbaum, L., Machan, J. T., Charney, D. A. & Kotler, D. P. Nonalcoholic fatty liver disease in severely obese subjects. Am. J. Gastroenterol. 102, 399\u2013408 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrendo201172_CR24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jhep.2006.06.013","volume":"45","author":"M Machado","year":"2006","unstructured":"Machado, M., Marques-Vidal, P. & Cortez-Pinto, H. Hepatic histology in obese patients undergoing bariatric surgery. J. Hepatol. 45, 600\u2013606 (2006).","journal-title":"J. Hepatol."},{"key":"BFnrendo201172_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1440-1746.2004.03312.x","volume":"19","author":"P Gupte","year":"2004","unstructured":"Gupte, P. et al. Non-alcoholic steatohepatitis in type 2 diabetes mellitus. J. Gastroenterol. Hepatol. 19, 854\u2013858 (2004).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrendo201172_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/gast.2001.23256","volume":"120","author":"AJ Sanyal","year":"2001","unstructured":"Sanyal, A. J. et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 1183\u20131192 (2001).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR27","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cgh.2008.03.005","volume":"6","author":"S Jacqueminet","year":"2008","unstructured":"Jacqueminet, S. et al. Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes. Clin. Gastroenterol. Hepatol. 6, 828\u2013831 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrendo201172_CR28","doi-asserted-by":"publisher","first-page":"E526","DOI":"10.1503\/cmaj.092144","volume":"182","author":"L Porepa","year":"2010","unstructured":"Porepa, L., Ray, J. G., Sanchez-Romeu, P. & Booth, G. L. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ 182, E526\u2013E531 (2010).","journal-title":"CMAJ"},{"key":"BFnrendo201172_CR29","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2337\/dc06-0455","volume":"29","author":"FG Toledo","year":"2006","unstructured":"Toledo, F. G., Sniderman, A. D. & Kelley, D. E. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care 29, 1845\u20131850 (2006).","journal-title":"Diabetes Care"},{"key":"BFnrendo201172_CR30","doi-asserted-by":"publisher","first-page":"E906","DOI":"10.1152\/ajpendo.00117.2003","volume":"285","author":"DE Kelley","year":"2003","unstructured":"Kelley, D. E., McKolanis, T. M., Hegazi, R. A., Kuller, L. H. & Kalhan, S. C. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am. J. Physiol. Endocrinol. Metab. 285, E906\u2013E916 (2003).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo201172_CR31","first-page":"846","volume":"19","author":"MA Banerji","year":"1995","unstructured":"Banerji, M. A. et al. Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int. J. Obes. Relat. Metab. Disord. 19, 846\u2013850 (1995).","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"BFnrendo201172_CR32","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1038\/ajg.2010.18","volume":"105","author":"LA Adams","year":"2010","unstructured":"Adams, L. A. et al. Nonalcoholic fatty liver disease increases risk of death among patients with diabetes: a community-based cohort study. Am. J. Gastroenterol. 105, 1567\u20131573 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrendo201172_CR33","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/hep.1840120505","volume":"12","author":"IR Wanless","year":"1990","unstructured":"Wanless, I. R. & Lentz, J. S. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12, 1106\u20131110 (1990).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/S1542-3565(04)00014-X","volume":"2","author":"ZM Younossi","year":"2004","unstructured":"Younossi, Z. M., Gramlich, T., Matteoni, C. A., Boparai, N. & McCullough, A. J. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin. Gastroenterol. Hepatol. 2, 262\u2013265 (2004).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrendo201172_CR35","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S0016-5085(00)70364-7","volume":"118","author":"V Ratziu","year":"2000","unstructured":"Ratziu, V. et al. Liver fibrosis in overweight patients. Gastroenterology 118, 1117\u20131123 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR36","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jhep.2004.09.012","volume":"42","author":"LA Adams","year":"2005","unstructured":"Adams, L. A., Sanderson, S., Lindor, K. D. & Angulo, P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J. Hepatol. 42, 132\u2013138 (2005).","journal-title":"J. Hepatol."},{"key":"BFnrendo201172_CR37","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni, C. A. et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116, 1413\u20131419 (1999).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR38","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/gut.2003.019984","volume":"53","author":"S Dam-Larsen","year":"2004","unstructured":"Dam-Larsen, S. et al. Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut 53, 750\u2013755 (2004).","journal-title":"Gut"},{"key":"BFnrendo201172_CR39","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1056\/NEJMra0912063","volume":"363","author":"G Targher","year":"2010","unstructured":"Targher, G., Day, C. P. & Bonora, E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N. Engl. J. Med. 363, 1341\u20131350 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201172_CR40","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1464-5491.2006.01817.x","volume":"23","author":"G Targher","year":"2006","unstructured":"Targher, G. et al. Increased prevalence of cardiovascular disease in type 2 diabetic patients with non-alcoholic fatty liver disease. Diabet. Med. 23, 403\u2013409 (2006).","journal-title":"Diabet. Med."},{"key":"BFnrendo201172_CR41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF03349177","volume":"29","author":"G Targher","year":"2006","unstructured":"Targher, G. et al. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients. J. Endocrinol. Invest. 29, 55\u201360 (2006).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo201172_CR42","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","volume":"54","author":"G Targher","year":"2005","unstructured":"Targher, G. et al. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 54, 3541\u20133546 (2005).","journal-title":"Diabetes"},{"key":"BFnrendo201172_CR43","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/j.1464-5491.2005.01646.x","volume":"22","author":"G Targher","year":"2005","unstructured":"Targher, G. et al. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet. Med. 22, 1354\u20131358 (2005).","journal-title":"Diabet. Med."},{"key":"BFnrendo201172_CR44","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.1152\/ajpendo.00604.2005","volume":"291","author":"R Lautam\u00e4ki","year":"2006","unstructured":"Lautam\u00e4ki, R. et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 291, E282\u2013E290 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo201172_CR45","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2337\/dc06-1982","volume":"30","author":"ES Kilpatrick","year":"2007","unstructured":"Kilpatrick, E. S., Rigby, A. S. & Atkin, S. L. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: \u201cdouble diabetes\u201d in the Diabetes Control and Complications Trial. Diabetes Care 30, 707\u2013712 (2007).","journal-title":"Diabetes Care"},{"key":"BFnrendo201172_CR46","doi-asserted-by":"crossref","first-page":"476","DOI":"10.5694\/j.1326-5377.2000.tb139299.x","volume":"173","author":"ND Manton","year":"2000","unstructured":"Manton, N. D. et al. Non-alcoholic steatohepatitis in children and adolescents. Med. J. Aust. 173, 476\u2013479 (2000).","journal-title":"Med. J. Aust."},{"key":"BFnrendo201172_CR47","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1464-5491.2009.02839.x","volume":"26","author":"JS Leeds","year":"2009","unstructured":"Leeds, J. S. et al. Abnormal liver function tests in patients with type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies. Diabet. Med. 26, 1235\u20131241 (2009).","journal-title":"Diabet. Med."},{"key":"BFnrendo201172_CR48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jhep.2010.04.030","volume":"53","author":"G Targher","year":"2010","unstructured":"Targher, G. et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes. J. Hepatol. 53, 713\u2013718 (2010).","journal-title":"J. Hepatol."},{"key":"BFnrendo201172_CR49","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/00000478-200604000-00012","volume":"30","author":"M Torbenson","year":"2006","unstructured":"Torbenson, M. et al. Glycogenic hepatopathy: an underrecognized hepatic complication of diabetes mellitus. Am. J. Surg. Pathol. 30, 508\u2013513 (2006).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrendo201172_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0002-9343(99)00315-0","volume":"108","author":"VM Struben","year":"2000","unstructured":"Struben, V. M., Hespenheide, E. E. & Caldwell, S. H. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am. J. Med. 108, 9\u201313 (2000).","journal-title":"Am. J. Med."},{"key":"BFnrendo201172_CR51","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1002\/hep.22726","volume":"49","author":"R Guerrero","year":"2009","unstructured":"Guerrero, R., Vega, G. L., Grundy, S. M. & Browning, J. D. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 49, 791\u2013801 (2009).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR52","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/hep.20554","volume":"41","author":"SR Weston","year":"2005","unstructured":"Weston, S. R. et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 41, 372\u2013379 (2005).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR53","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01823.x","volume":"29","author":"A Riquelme","year":"2009","unstructured":"Riquelme, A. et al. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int. 29, 82\u201388 (2009).","journal-title":"Liver Int."},{"key":"BFnrendo201172_CR54","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jhep.2008.11.017","volume":"50","author":"SR Mohanty","year":"2009","unstructured":"Mohanty, S. R. et al. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J. Hepatol. 50, 797\u2013804 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrendo201172_CR55","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1053\/j.gastro.2009.03.020","volume":"136","author":"EK Speliotes","year":"2009","unstructured":"Speliotes, E. K. Genetics of common obesity and nonalcoholic fatty liver disease. Gastroenterology 136, 1492\u20131495 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR56","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1053\/j.gastro.2009.01.050","volume":"136","author":"JB Schwimmer","year":"2009","unstructured":"Schwimmer, J. B. et al. Heritability of nonalcoholic fatty liver disease. Gastroenterology 136, 1585\u20131592 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR57","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/oby.2009.4","volume":"17","author":"LE Wagenknecht","year":"2009","unstructured":"Wagenknecht, L. E. et al. Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort. Obesity (Silver Spring) 17, 1240\u20131246 (2009).","journal-title":"Obesity (Silver Spring)"},{"key":"BFnrendo201172_CR58","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1097\/MOL.0b013e328338ca61","volume":"21","author":"S Romeo","year":"2010","unstructured":"Romeo, S., Huang-Doran, I., Baroni, M. G. & Kotronen, A. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein. Curr. Opin. Lipidol. 21, 247\u2013252 (2010).","journal-title":"Curr. Opin. Lipidol."},{"key":"BFnrendo201172_CR59","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo, S. et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 40, 1461\u20131465 (2008).","journal-title":"Nat. Genet."},{"key":"BFnrendo201172_CR60","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1002\/hep.23622","volume":"51","author":"L Valenti","year":"2010","unstructured":"Valenti, L. et al. Homozygosity for the patatin-like phospholipase-3\/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51, 1209\u20131217 (2010).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR61","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000282098","volume":"28","author":"CP Day","year":"2010","unstructured":"Day, C. P. Genetic and environmental susceptibility to non-alcoholic fatty liver disease. Dig. Dis. 28, 255\u2013260 (2010).","journal-title":"Dig. Dis."},{"key":"BFnrendo201172_CR62","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","volume":"362","author":"KF Petersen","year":"2010","unstructured":"Petersen, K. F. et al. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. N. Engl. J. Med. 362, 1082\u20131089 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201172_CR63","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1503\/cmaj.045232","volume":"172","author":"LA Adams","year":"2005","unstructured":"Adams, L. A., Angulo, P. & Lindor, K. D. Nonalcoholic fatty liver disease. CMAJ 172, 899\u2013905 (2005).","journal-title":"CMAJ"},{"key":"BFnrendo201172_CR64","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1172\/JCI200422422","volume":"114","author":"JD Browning","year":"2004","unstructured":"Browning, J. D. & Horton, J. D. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 114, 147\u2013152 (2004).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201172_CR65","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1053\/jhep.2002.32527","volume":"35","author":"M Charlton","year":"2002","unstructured":"Charlton, M., Sreekumar, R., Rasmussen, D., Lindor, K. & Nair, K. S. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology 35, 898\u2013904 (2002).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR66","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/hep.23719","volume":"52","author":"BA Neuschwander-Tetri","year":"2010","unstructured":"Neuschwander-Tetri, B. A. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 52, 774\u2013788 (2010).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR67","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1586\/egh.09.32","volume":"3","author":"N Alkhouri","year":"2009","unstructured":"Alkhouri, N., Dixon, L. J. & Feldstein, A. E. Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal. Expert Rev. Gastroenterol. Hepatol. 3, 445\u2013451 (2009).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"BFnrendo201172_CR68","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","volume":"6","author":"M Monetti","year":"2007","unstructured":"Monetti, M. et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell. Metab. 6, 69\u201378 (2007).","journal-title":"Cell. Metab."},{"key":"BFnrendo201172_CR69","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1074\/jbc.M807616200","volume":"284","author":"ZZ Li","year":"2009","unstructured":"Li, Z. Z., Berk, M., McIntyre, T. M. & Feldstein, A. E. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J. Biol. Chem. 284, 5637\u20135644 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo201172_CR70","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.molcel.2007.07.008","volume":"27","author":"A Jaeschke","year":"2007","unstructured":"Jaeschke, A. & Davis, R. J. Metabolic stress signaling mediated by mixed-lineage kinases. Mol. Cell 27, 498\u2013508 (2007).","journal-title":"Mol. Cell"},{"key":"BFnrendo201172_CR71","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860\u2013867 (2006).","journal-title":"Nature"},{"key":"BFnrendo201172_CR72","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1074\/jbc.275.12.9047","volume":"275","author":"V Aguirre","year":"2000","unstructured":"Aguirre, V., Uchida, T., Yenush, L., Davis, R. & White, M. F. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275, 9047\u20139054 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo201172_CR73","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ceb.2007.02.001","volume":"19","author":"CR Weston","year":"2007","unstructured":"Weston, C. R. & Davis, R. J. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19, 142\u2013149 (2007).","journal-title":"Curr. Opin. Cell Biol."},{"key":"BFnrendo201172_CR74","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1126\/science.1160794","volume":"322","author":"G Sabio","year":"2008","unstructured":"Sabio, G. et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322, 1539\u20131543 (2008).","journal-title":"Science"},{"key":"BFnrendo201172_CR75","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.cmet.2007.09.011","volume":"6","author":"G Solinas","year":"2007","unstructured":"Solinas, G. et al. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell. Metab. 6, 386\u2013397 (2007).","journal-title":"Cell. Metab."},{"key":"BFnrendo201172_CR76","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature01137","volume":"420","author":"J Hirosumi","year":"2002","unstructured":"Hirosumi, J. et al. A central role for JNK in obesity and insulin resistance. Nature 420, 333\u2013336 (2002).","journal-title":"Nature"},{"key":"BFnrendo201172_CR77","doi-asserted-by":"publisher","first-page":"9887","DOI":"10.1074\/jbc.M410310200","volume":"280","author":"JM Schattenberg","year":"2005","unstructured":"Schattenberg, J. M., Wang, Y., Singh, R., Rigoli, R. M. & Czaja, M. J. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J. Biol. Chem. 280, 9887\u20139894 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo201172_CR78","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","volume":"103","author":"A Wieckowska","year":"2008","unstructured":"Wieckowska, A. et al. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am. J. Gastroenterol. 103, 1372\u20131379 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrendo201172_CR79","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.1074\/jbc.M210689200","volume":"278","author":"JJ Senn","year":"2003","unstructured":"Senn, J. J. et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J. Biol. Chem. 278, 13740\u201313746 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrendo201172_CR80","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai, D. et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11, 183\u2013190 (2005).","journal-title":"Nat. Med."},{"key":"BFnrendo201172_CR81","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.22350","volume":"48","author":"D van der Poorten","year":"2008","unstructured":"van der Poorten, D. et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 48, 449\u2013457 (2008).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR82","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","volume":"11","author":"MM Ibrahim","year":"2010","unstructured":"Ibrahim, M. M. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 11, 11\u201318 (2010).","journal-title":"Obes. Rev."},{"key":"BFnrendo201172_CR83","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796\u20131808 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201172_CR84","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1172\/JCI29069","volume":"116","author":"SE Shoelson","year":"2006","unstructured":"Shoelson, S. E., Lee, J. & Goldfine, A. B. Inflammation and insulin resistance. J. Clin. Invest. 116, 1793\u20131801 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201172_CR85","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI25102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen, K. E. & Hotamisligil, G. S. Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111\u20131119 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo201172_CR86","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hep.20280","volume":"40","author":"JM Hui","year":"2004","unstructured":"Hui, J. M. et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 40, 46\u201354 (2004).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR87","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0168-8278(02)00102-2","volume":"37","author":"IA Leclercq","year":"2002","unstructured":"Leclercq, I. A., Farrell, G. C., Schriemer, R. & Robertson, G. R. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J. Hepatol. 37, 206\u2013213 (2002).","journal-title":"J. Hepatol."},{"key":"BFnrendo201172_CR88","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1053\/jhep.2002.34359","volume":"36","author":"FA Anania","year":"2002","unstructured":"Anania, F. A. Leptin, liver, and obese mice\u2014fibrosis in the fat lane. Hepatology 36, 246\u2013248 (2002).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.20283","volume":"40","author":"AE Feldstein","year":"2004","unstructured":"Feldstein, A. E. et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40, 185\u2013194 (2004).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR90","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1053\/bega.2002.0325","volume":"16","author":"M Haque","year":"2002","unstructured":"Haque, M. & Sanyal, A. J. The metabolic abnormalities associated with non-alcoholic fatty liver disease. Best Pract. Res. Clin. Gastroenterol. 16, 709\u2013731 (2002).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"BFnrendo201172_CR91","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1053\/jhep.2001.28055","volume":"34","author":"V Paradis","year":"2001","unstructured":"Paradis, V. et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology 34, 738\u2013744 (2001).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR92","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1111\/j.1478-3231.2005.01130.x","volume":"25","author":"R Sugimoto","year":"2005","unstructured":"Sugimoto, R. et al. High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase. Liver Int. 25, 1018\u20131026 (2005).","journal-title":"Liver Int."},{"key":"BFnrendo201172_CR93","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh, S. et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745\u2013750 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR94","doi-asserted-by":"publisher","first-page":"473","DOI":"10.7326\/0003-4819-111-6-473","volume":"111","author":"MM Van Ness","year":"1989","unstructured":"Van Ness, M. M. & Diehl, A. M. Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes? Ann. Intern. Med. 111, 473\u2013478 (1989).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo201172_CR95","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1053\/j.gastro.2008.02.077","volume":"134","author":"DM Torres","year":"2008","unstructured":"Torres, D. M. & Harrison, S. A. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 134, 1682\u20131698 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR96","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"AL Fracanzani","year":"2008","unstructured":"Fracanzani, A. L. et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology 48, 792\u2013798 (2008).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR97","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cld.2004.06.008","volume":"8","author":"SA Harrison","year":"2004","unstructured":"Harrison, S. A. & Neuschwander-Tetri, B. A. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin. Liver Dis. 8, 861\u2013879 (2004).","journal-title":"Clin. Liver Dis."},{"key":"BFnrendo201172_CR98","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/j.1478-3231.2008.01920.x","volume":"29","author":"JW Yun","year":"2009","unstructured":"Yun, J. W. et al. Abnormal glucose tolerance in young male patients with nonalcoholic fatty liver disease. Liver Int. 29, 525\u2013529 (2009).","journal-title":"Liver Int."},{"key":"BFnrendo201172_CR99","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","volume":"38","author":"B Palmentieri","year":"2006","unstructured":"Palmentieri, B. et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig. Liver Dis. 38, 485\u2013489 (2006).","journal-title":"Dig. Liver Dis."},{"key":"BFnrendo201172_CR100","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","volume":"102","author":"M Hamaguchi","year":"2007","unstructured":"Hamaguchi, M. et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am. J. Gastroenterol. 102, 2708\u20132715 (2007).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrendo201172_CR101","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1381\/096089204323093408","volume":"14","author":"CC Mottin","year":"2004","unstructured":"Mottin, C. C. et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes. Surg. 14, 635\u2013637 (2004).","journal-title":"Obes. Surg."},{"key":"BFnrendo201172_CR102","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cgh.2008.11.023","volume":"7","author":"SM Mazhar","year":"2009","unstructured":"Mazhar, S. M., Shiehmorteza, M. & Sirlin, C. B. Noninvasive assessment of hepatic steatosis. Clin. Gastroenterol. Hepatol. 7, 135\u2013140 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrendo201172_CR103","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0730-725X(96)00224-X","volume":"15","author":"MH Fishbein","year":"1997","unstructured":"Fishbein, M. H., Gardner, K. G., Potter, C. J., Schmalbrock, P. & Smith, M. A. Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn. Reson. Imaging 15, 287\u2013293 (1997).","journal-title":"Magn. Reson. Imaging"},{"key":"BFnrendo201172_CR104","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cld.2007.02.014","volume":"11","author":"P Charatcharoenwitthaya","year":"2007","unstructured":"Charatcharoenwitthaya, P. & Lindor, K. D. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin. Liver Dis. 11, 37\u201354 (2007).","journal-title":"Clin. Liver Dis."},{"key":"BFnrendo201172_CR105","doi-asserted-by":"publisher","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","volume":"288","author":"LS Szczepaniak","year":"2005","unstructured":"Szczepaniak, L. S. et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462\u2013E468 (2005).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo201172_CR106","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.jhep.2010.04.018","volume":"53","author":"E Roldan-Valadez","year":"2010","unstructured":"Roldan-Valadez, E. et al. In vivo 3T spectroscopic quantification of liver fat content in nonalcoholic fatty liver disease: Correlation with biochemical method and morphometry. J. Hepatol. 53, 732\u2013737 (2010).","journal-title":"J. Hepatol."},{"key":"BFnrendo201172_CR107","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","volume":"94","author":"EM Brunt","year":"1999","unstructured":"Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A. & Bacon, B. R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467\u20132474 (1999).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrendo201172_CR108","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1053\/j.gastro.2005.04.014","volume":"129","author":"LA Adams","year":"2005","unstructured":"Adams, L. A. et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129, 113\u2013121 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR109","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5858\/2006-130-27-DHDMOT","volume":"130","author":"SA Harrison","year":"2006","unstructured":"Harrison, S. A., Brunt, E. M., Goodman, Z. D. & Di Bisceglie, A. M. Diabetic hepatosclerosis: diabetic microangiopathy of the liver. Arch. Pathol. Lab. Med. 130, 27\u201332 (2006).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrendo201172_CR110","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson, S., Stewart, S. F., Henderson, E., Burt, A. D. & Day, C. P. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut 59, 1265\u20131269 (2010).","journal-title":"Gut"},{"key":"BFnrendo201172_CR111","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/hep.21984","volume":"47","author":"IN Guha","year":"2008","unstructured":"Guha, I. N. et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 47, 455\u2013460 (2008).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR112","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.23312","volume":"51","author":"VW Wong","year":"2010","unstructured":"Wong, V. W. et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51, 454\u2013462 (2010).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR113","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","volume":"53","author":"V Ratziu","year":"2010","unstructured":"Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD\/NASH based on the EASL 2009 special conference. J. Hepatol. 53, 372\u2013384 (2010).","journal-title":"J. Hepatol."},{"key":"BFnrendo201172_CR114","doi-asserted-by":"publisher","first-page":"E829","DOI":"10.1152\/ajpendo.00133.2006","volume":"292","author":"L Juurinen","year":"2007","unstructured":"Juurinen, L., Tiikkainen, M., H\u00e4kkinen, A. M., Hakkarainen, A. & Yki-J\u00e4rvinen, H. Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes. Am. J. Physiol. Endocrinol. Metab. 292, E829\u2013E835 (2007).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrendo201172_CR115","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/hep.23711","volume":"52","author":"NA Johnson","year":"2010","unstructured":"Johnson, N. A. & George, J. Fitness versus fatness: moving beyond weight loss in nonalcoholic fatty liver disease. Hepatology 52, 370\u2013381 (2010).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR116","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2337\/dc05-2565","volume":"29","author":"DE Larson-Meyer","year":"2006","unstructured":"Larson-Meyer, D. E. et al. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 29, 1337\u20131344 (2006).","journal-title":"Diabetes Care"},{"key":"BFnrendo201172_CR117","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","volume":"54","author":"KF Petersen","year":"2005","unstructured":"Petersen, K. F. et al. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes 54, 603\u2013608 (2005).","journal-title":"Diabetes"},{"key":"BFnrendo201172_CR118","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1210\/jc.2004-1959","volume":"90","author":"Y Tamura","year":"2005","unstructured":"Tamura, Y. et al. Effects of diet and exercise on muscle and liver intracellular lipid contents and insulin sensitivity in type 2 diabetic patients. J. Clin. Endocrinol. Metab. 90, 3191\u20133196 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo201172_CR119","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1111\/j.1572-0241.2005.41334.x","volume":"100","author":"MA Huang","year":"2005","unstructured":"Huang, M. A. et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am. J. Gastroenterol. 100, 1072\u20131081 (2005).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrendo201172_CR120","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/hep.23276","volume":"51","author":"K Promrat","year":"2010","unstructured":"Promrat, K. et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51, 121\u2013129 (2010).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR121","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/hep.22575","volume":"49","author":"SA Harrison","year":"2009","unstructured":"Harrison, S. A., Fecht, W., Brunt, E. M. & Neuschwander-Tetri, B. A. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. Hepatology 49, 80\u201386 (2009).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR122","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/hep.22940","volume":"50","author":"A St George","year":"2009","unstructured":"St George, A. et al. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 50, 68\u201376 (2009).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR123","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa066254","volume":"357","author":"L Sj\u00f6str\u00f6m","year":"2007","unstructured":"Sj\u00f6str\u00f6m, L. et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N. Engl. J. Med. 357, 741\u2013752 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201172_CR124","doi-asserted-by":"crossref","unstructured":"Chavez-Tapia, N. C. et al. Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD007340. doi:10.1002\/14651858.CD007340.pub2 (2010).","DOI":"10.1002\/14651858.CD007340.pub2"},{"key":"BFnrendo201172_CR125","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1001\/archinte.168.19.2070","volume":"168","author":"E Selvin","year":"2008","unstructured":"Selvin, E. et al. Cardiovascular outcomes in trials of oral diabetes medications: a systematic review. Arch. Intern. Med. 168, 2070\u20132080 (2008).","journal-title":"Arch. Intern. Med."},{"key":"BFnrendo201172_CR126","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/hep.23623","volume":"52","author":"G Musso","year":"2010","unstructured":"Musso, G., Gambino, R., Cassader, M. & Pagano, G. A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology 52, 79\u2013104 (2010).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR127","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","volume":"135","author":"GP Aithal","year":"2008","unstructured":"Aithal, G. P. et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology 135, 1176\u20131184 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR128","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1056\/NEJMoa060326","volume":"355","author":"R Belfort","year":"2006","unstructured":"Belfort, R. et al. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. N. Engl. J. Med. 355, 2297\u20132307 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201172_CR129","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal, A. J. et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1675\u20131685 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201172_CR130","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","volume":"135","author":"V Ratziu","year":"2008","unstructured":"Ratziu, V. et al. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology 135, 100\u2013110 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrendo201172_CR131","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/MEG.0b013e32832e2baf","volume":"22","author":"Z Omer","year":"2010","unstructured":"Omer, Z. et al. Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease. Eur. J. Gastroenterol. Hepatol. 22, 18\u201323 (2010).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrendo201172_CR132","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa072761","volume":"356","author":"SE Nissen","year":"2007","unstructured":"Nissen, S. E. & Wolski, K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 356, 2457\u20132471 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrendo201172_CR133","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/pgmj.2005.042200","volume":"82","author":"LA Adams","year":"2006","unstructured":"Adams, L. A. & Angulo, P. Treatment of non-alcoholic fatty liver disease. Postgrad. Med. J. 82, 315\u2013322 (2006).","journal-title":"Postgrad. Med. J."},{"key":"BFnrendo201172_CR134","doi-asserted-by":"publisher","first-page":"143","DOI":"10.7326\/0003-4819-143-2-200507190-00014","volume":"143","author":"E Guallar","year":"2005","unstructured":"Guallar, E., Hanley, D. F. & Miller E. R. 3rd. An editorial update: Annus horribilis for vitamin E. Ann. Intern. Med. 143, 143\u2013145 (2005).","journal-title":"Ann. Intern. Med."},{"key":"BFnrendo201172_CR135","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/hep.20092","volume":"39","author":"KD Lindor","year":"2004","unstructured":"Lindor, K. D. et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology 39, 770\u2013778 (2004).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR136","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/hep.23727","volume":"52","author":"UF Leuschner","year":"2010","unstructured":"Leuschner, U. F. et al. High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trial. Hepatology 52, 472\u2013479 (2010).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR137","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1002\/hep.23239","volume":"50","author":"MF Abdelmalek","year":"2009","unstructured":"Abdelmalek, M. F. et al. Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology 50, 1818\u20131826 (2009).","journal-title":"Hepatology"},{"key":"BFnrendo201172_CR138","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/ajg.2009.719","volume":"105","author":"M Malaguarnera","year":"2010","unstructured":"Malaguarnera, M. et al. L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis\u2014a randomized and controlled clinical trial. Am. J. Gastroenterol. 105, 1338\u20131345 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrendo201172_CR139","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3748\/wjg.15.942","volume":"15","author":"EF Georgescu","year":"2009","unstructured":"Georgescu, E. F., Ionescu, R., Niculescu, M., Mogoanta, L. & Vancica, L. Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis. World J. Gastroenterol. 15, 942\u2013954 (2009).","journal-title":"World J. Gastroenterol."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2011.72.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2011.72","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2011.72.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T13:27:40Z","timestamp":1741181260000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2011.72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,10]]},"references-count":139,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["BFnrendo201172"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2011.72","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,10]]}}}